Skip to Content
Merck
All Photos(1)

Key Documents

Y0000468

Brotizolam

European Pharmacopoeia (EP) Reference Standard

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C15H10BrClN4S
CAS Number:
57801-81-7
Molecular Weight:
393.69
UNSPSC Code:
41116107
NACRES:
NA.24
Product Y0000468 is not currently sold in your country. Contact Technical Service

grade

pharmaceutical primary standard

API family

brotizolam

manufacturer/tradename

EDQM

drug control

psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

[s]1c2c(cc1Br)C(=NCc4[n]2c(nn4)C)c3c(cccc3)Cl

InChI

1S/C15H10BrClN4S/c1-8-19-20-13-7-18-14(9-4-2-3-5-11(9)17)10-6-12(16)22-15(10)21(8)13/h2-6H,7H2,1H3

InChI key

UMSGKTJDUHERQW-UHFFFAOYSA-N

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Brotizolam EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

related product

Product No.
Description
Pricing

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

T Osanai et al.
British journal of clinical pharmacology, 58(5), 476-481 (2004-11-04)
To assess the effect of itraconazole, a potent inhibitor of cytochrome P450 (CYP)3A4, on the single oral dose pharmacokinetics and pharmacodynamics of brotizolam. In this randomized, double-blind, cross-over trial 10 healthy male subjects received either itraconazole 200 mg or matched
Tomoki Nishiyama et al.
Journal of anesthesia, 21(1), 7-12 (2007-02-08)
The purpose of this study was to evaluate the effects of quazepam, a long-acting hypnotic, as a preoperative night medication in comparison with brotizolam, a shortacting hypnotic. Two hundred patients (aged 30 to 70 years) admitted for elective general anesthesia
Paradoxical reactions to hypnotic agents in adolescents with free-running disorder.
Masaru Echizenya et al.
Psychiatry and clinical neurosciences, 63(3), 428-428 (2009-07-02)
Atsushi Takiguchi et al.
Journal of pharmacological sciences, 101(4), 325-328 (2006-08-08)
Triazolam caused no significant increase in the total error at 0.05 and 0.1 mg/kg. However, at 0.2 mg/kg, it caused a significant increase in total error. Almost the same findings were observed with brotizolam and rilmazafone. That is, at 0.2
Yoshinori Sugimoto et al.
Bioorganic & medicinal chemistry letters, 23(12), 3515-3518 (2013-05-15)
When the drug product of brotizolam (1) is decomposed according to the interview form and patent, hydrolysate (2) is obtained, but its physicochemical data are still missing. To elucidate the structure based on a spectroscopic approach, the above-mentioned degradation product
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service